(Last of two parts) As we usher in the new year, I remember Mang Sandro, whom we met while vacationing...
A patient who had been having fever and cough for several days felt like the roof of the emergency room...
(First of a series) In this series of commentaries, we’d like to highlight the following: Preventing the Delta or Indian...
(Conclusion) Many have been asking us when we could attain herd immunity in our country. Many still have the impression...
Based on a study of people up to eight months after a COVID-19 infection, more than 95 percent still have...
Last week, we discussed how history seems to be repeating itself with a one-size-fits-all strategy of mass vaccination for COVID-19,...
It may come as a surprise, but recent data suggest that vaccinated individuals may be the potential superspreaders of the...
It’s par for the course when you write commentaries that you get both positive and negative comments. A certain Gochong...
(First of two parts) In the past several days, some readers have asked us about the new antiviral drug molnupiravir,...
(First of two parts) On Oct. 15, the government began the vaccination for minors against COVID-19. We have extensively discussed...
